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Pseudohypoparathyroidism and Related Disorders 
C D . Au rbach , M D * 
f d. Note - This overview was originally presented at the 
International Symposium on Clinical Disorders of Bone 
and Mineral Metabolism, May 9-13,1983. The following 
list indicates the presentations given in this session at the 
Symposium and the contents ofthe corresponding chap-
ter in the Proceedings of the Symposium published by 
Excerpta Medica. The numbers in parentheses refer to 
pages in this volume. Complete information about the 
contents of the Proceedings can be found at the back of 
this issue. 
Molecular basis of pseudohypoparathyroidism. C. Van 
Dop and H.R. Bourne (453) 
Parathyroid hormone bioactivity in familial pseudohypo-
parathyroidism type I. J.A. Fischer, C. Nagant de Deux-
chaisnes, N. Loveridge, M.A. Dambacher, F. Tschopp, E. 
Werder, L. Bitensky, and J. Chayen (459) 
Resistance to mult iple hormones in pseudohypopara-
thyroidism: Association with deficient activity of gua-
nine nucleotide regulatory protein. M.A. Levine, R.W. 
Downs Jr, and A .M. Speigel (464) 
Inherent and acquired resistance to parathyroid hor-
mone in man. J.L.H. O'Riordan, G.N. Hendy, and I.G. 
Lewin (469) 
1 n 1942, Albright and his associates (1) described for the 
first t ime a syndrome of true hormone resistance, which 
they called pseudohypoparathyroidism or Sebright 
Bantam syndrome.! The classical syndrome of pseudo-
hypoparathyroidism type 1 encompasses not only clinical 
hypoparathyroidism with hypocalcemia and hyperphos-
phatemia, but also certain associated constitutional fea-
tures, including short stature, round facies, obesity, ten-
dency to mental retardation, shortening of the metacarpal 
and metatarsal bones, and subcutaneous calcifications. 
The associated constitutional features have also been 
designated Albright's hereditary osteodystrophy (AHO). 
The original authors found that the subjects were resist-
ant to exogenous parathyroid hormone when tested by 
the phosphaturic response. This test has been replaced 
by determining the urinary cyclic AMP response to 
exogenous parathyroid hormone. The latter test more 
efficiently segregates subjects with classical pseudohypo-
parathyroidism from normal subjects and from those 
with other forms of hypoparathyroidism. Albright and 
his associates, and many others through the years since 
their original report, proposed a number of hypotheses 
to explain the biochemical abnormality and mode of 
inheritance of pseudohypoparathyroidism. Among the 
hypotheses considered by Albright were end-organ re-
sistance to normally secreted parathyroid hormone, anti-
bodies to parathyroid hormone, and secretion by para-
thyroid glands of an abnormal peptide capable of 
blocking the actions of parathyroid hormone (PTH). 
The findings of Chase, et al (2) of defective product ion of 
cyclic AMP in response to PTH redirected attention to 
the concept of end-organ resistance and led to the 
hypothesis that pseudohypoparathyroidism represented 
a defect in the parathyroid hormone receptor-adenylate 
cyclase system accounting for end-organ resistance. 
Subsequent investigations have found that the cell 
membrane content of the guanyl nucleotide regulatory 
protein (G-unit that couples receptor activity to adeny-
tNamed aher the Sebright Bantam cock, which he thought was resistant to andro-
gens. Recently, it has been proved that the female tail-feathering pattern in this 
variant is not due to resistance to androgens, but rather to an abnormally increased 
rate of conversion of androgens to estrogens by the skin of these birds (5). 
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late cyclase activity) is deficient in most cases of classical 
pseudohypoparathyroidism with AHO (3,4). Many of the 
other hypotheses, including antibody to hormone, have 
been excluded, but recently the concept of an endo-
genous inhibitor, presumably an abnormal hormone 
secreted by the parathyroid gland capable of blocking 
receptors, has once again come under consideration. 
Fischer (6) presented data obtained with Chayen to indi-
cate that in the plasma of patients with pseudohypopara-
thyroidism there is an abnormally high ratio of radio-
immunoassayable parathyroid hormone relative to 
bioassayable parathyroid hormone. Moreover, they have 
found evidence for inhibitory activity in the plasma of 
patients with pseudohypoparathyroidism (7). This evi-
dence was determined by adding parathyroid hormone 
to plasma and carrying out bioassays uti l izing the in vitro 
cytochemical bioassay (CBA) for parathyroid hormone 
developed by the Chayen group (8). Nevertheless, con-
siderable amounts of bioactive parathyroid hormone 
have been detected by two groups, Fischer, et al (pp. 459 
ff.) and O'Riordan, et al (pp. 469), applying the CBA assay 
in pseudohypoparathyroidism; and the amounts founci 
overlap the normal and hyperparathyroid ranges. 
Another point to consider is that in any condit ion of 
excess hormone secretion (primary or secondary hyper-
parathyroidism) the kidney may develop resistance to 
the effects of parathyroid hormone. This effect, dis-
cussed by O'Riordan, might be attributable to "down 
regulat ion " of parathyroid hormone receptors induced 
by high concentrations of circulating hormone. Part of 
the hormone resistance in pseudohypoparathyroidism 
may be due to this down regulation phenomenon. On 
the other hand, subjects with pseudohypoparathyroid-
ism adequately treated with vitamin D or infused with 
calcium (to suppress PTH secretion) continue to express 
the resistance to exogenous parathyroid hormone as 
determined by urinary cyclin AMP excretion (2). More-
over, one totally parathyroidectomized patient with the 
disorder persistently displays the urinary cAMP response 
defect (2). Patients with hormone resistance in vitamin D 
deficiency show a correction of this defect after treat-
ment (O'Riordan, et al, pp. 469 ff.). 
Genetics of pseudohypoparathyroidism 
In the past, pseudohypoparathyroidism has been con-
sidered a sex-linked disorder. There are few docu-
mented cases of male-to-male transmission; the female: 
male sex ratio in the disorder is approximately 2 : 1 ; and 
pedigrees of families reported appear compatible with 
the sex-linked transmission mode. On the other hand, 
a few families do not fit this pattern; some pedigrees 
seem compatible with autosomal dominant inheritance, 
others with autosomal recessive transmission (Van Dop 
and Bourne, pp. 453 ff.). 
Part of the confusion concerning heredity stems from 
the fact that there are too few families with mult iple 
affected members to allow conclusive analysis of inheri-
tance patterns. Also, different investigators use differing 
parameters to examine patterns of heredity; parameters 
evaluated include phosphaturia, physiognomy, blood 
calcium analyses, urinary cyclic AMP responses, and 
assays for guanylnucleotide (G-unit) regulatory compo-
nent. Another reason for the confusion is that errors in 
measured parameters have not uniformly been analyzed 
statistically. One may arrive at a different conclusion 
about genetics usingthe urinary cyclic AMP responseon 
the one hand, or G-unit analyses on the other. Uti l izing 
G-unit analyses. Van Dop and Bourne found evidence 
that some families with the disorder may represent 
recessive or dominant autosomal patterns of inheri-
tance. They readily admitted, however, that pedigree 
analyses reported so far do not rule out X-linked inheri-
tance. Si nee the G-unit is composed of two subunits, it is 
possible that the gene control l ing one subunit is on the 
sex chromosome, and the other subunit could be 
represented on an autosomal chromosome. Such a 
mechanism might account for apparent diversity in 
inheritance. Other possible mechanisms are presented 
below. Another puzzling feature of the inheritance pat-
tern in pseudohypoparathyroidism is that deficiency 
of the G-unit averages approximately 50% and never 
approaches, as found in the cyclymphoma cell mutant, 
total deficiency, which in the human organism might be 
incompatible with life. 
What can one surmise about the biochemical nature of 
the disorder: deficiency of G-unit or product ion of 
abnormal form of hormone? It is dif f icult to postulate 
two distinct genetic defects to account for the same 
abnormality in any given subject. Moreover, product ion 
of a defective hormone seems unlikely to account for the 
generalized defect in hormone responsiveness described 
by Levine, et al (pp. 464 ff.). Perhaps deficiency of the 
G-unit, a protein control l ing adenylate cyclase in all 
tissues, can also influence the nature of the product 
secreted by the parathyroid cell, a process also regulated 
in part by cyclic AMP. Goltzman (9) has recently de-
scribed phosphorylated forms of parathyroid hormone. 
Phospho-proteins are regulated by protein kinases, 
some of which also are control led by cyclic AMP. If there 
was an abnormal distr ibution of phospho-forms elabo-
rated in pseudohypoparathyroidism due to diminished 
product ion of cyclic AMP in the parathyroid cell, one 
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might be able to explain a link between G-unit def i-
ciency and production of parathyroid hormone forms 
with varying immuno- to bio-activity. Since cyclic AMP 
has been implicated in control of chondrocyte function 
(10), it is also possiblethat brachydactyly in pseudohypo-
parathyroidism is another consequence of deficiency of 
the G-unit in the adenylate cyclase complex. 
Classically, autosomal dominant gene defects in heter-
ozygotes produce 50% reductions in enzyme activity, 
since loss of one of a gene pair yields one half of the 
normal complement of protein. Fifty percent loss of 
funct ion in genes carried on the X chromosome might 
occur in women due to mosaicism, but in affected men 
the loss of funct ion would be total. This is one of the 
problems that makes the postulate of sex linkage in 
pseudohypoparathyroidism diff icult; how would one 
explain thereby male subjects showing 50% of normal 
complement of the G-unit? Lessons learned in the study 
of thalassemia may be instructive. In certain forms of 
beta"*" thalassemia (11), the genomic information is nor-
mal, but a mutation in an intron causes a splicing defect 
with consequent abnormal processing of pre-mRNA. 
The net result is production of significant but reduced 
amounts of normal beta hemoglobin chains. Such a splic-
ing defect in biosynthesis of G-unit mRNA in pseudo-
hypoparathyroidism, if localized on the X chromosome, 
could account for 50% or greater reduction in comple-
ment of the protein and be compatible with sex-linked 
inheritance. Studies in thalassemia (11) indicatethatsim-
ilar phenotypic expressions of disease can be caused by 
many different types of mutations in the genes responsi-
ble for hemoglobin synthesis. Like the G-unit, hemo-
globin is composed of two different alpha and beta pro-
tein subunits. Different genes normally control synthesis 
of each subunit (still other genes control synthesis of 
gamma and delta chains, which normally do not operate 
post nata lly). Mutations in either of the genes for alpha or 
beta chains can cause thalassemia, which may vary in 
severity from no discernible clinical effect to life-impairing 
disease. Moreover, compensatory synthesis of fetal hemo-
globins, not normally synthesized in the adult, can yield 
partially effective proteins. Perhaps in pseudohypopara-
thyroidism will be discovered a similarly remarkable 
diversity of genetic defects that would account for 
phenotypic expression of the disorder, which also seems 
to vary in severity. 
Currently, the best single unifying hypothesis to account 
for the genetic defect of pseudohypoparathyroidism 
with AHO is a deficiency of product ion of the G-unit. 
One must recognize, moreover, that more than one type 
of inheritance pattern and gene defect may account for 
the phenotype of this syndrome. Ultimate resolution of 
these problems depends upon structural determination 
of the G-unit protein and/or applications of recombi-
nant DNA technology to elucidate the defect at the 
polynucleotide level. 
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